Urinary metabolomic signatures associated with early adverse events during volumetric modulated arc therapy for prostate cancer: A secondary analysis of a public dataset.

Mol Clin Oncol · 2026 · PMC13172665 · PMID 42147137

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

nominally significantno p-value reported

Among these, TG (16:0_38:1) and DG (18:1_18:1) showed nominally significant differences between groups in the primary analysis, although this was not consistently observed in the sensitivity analysis.

also in 7,732 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.